Saturday, April 21, 2018
 
 
Company News: Page (1) of 1 - 04/09/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Mallinckrodt To Present At Deutsche Bank's 43rd Annual Healthcare Conference
 
(April 09, 2018)

STAINES-UPON-THAMES, United Kingdom, April 9, 2018 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, May 9, 2018, at Deutsche Bank's 43rd Annual Healthcare Conference at the Intercontinental Hotel Boston, 510 Atlantic Ave., in Boston.

Mallinckrodt logo

Mark Trudeau, President and Chief Executive Officer, and Dr. Steven Romano, Executive Vice President and Chief Scientific Officer, will represent the company in a fireside chat at 12:50 p.m. Eastern.   



Individuals who cannot attend the meeting in person can find webcast information at: http://www.mallinckrodt.com/investors. A replay will also be available following the meeting.

ABOUT MALLINCKRODT
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission (SEC) disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

CONTACTS

Investor Relations
Daniel J. Speciale, CPA
Investor Relations and Strategy Officer
314-654-3638
[email protected]

Media
Rhonda Sciarra
Senior Communications Manager
908-238-6765
[email protected] 

Meredith Fischer
Chief Public Affairs Officer
314-654-3318
[email protected] 

Mallinckrodt, the "M" brandmark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2018 04/18

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-deutsche-banks-43rd-annual-healthcare-conference-300625604.html

SOURCE Mallinckrodt Pharmaceuticals

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Pro AV,Presentors,Business,Business Issues,Internet Media,Presentation,Channel/Distribution, webcast,USA,Medicine,healthcare,Pregnancy,Surgery,Medication,Pregnancy,Science,Medical,Business,Other,
Related Sites: Digital Producer ,   Digital Webcast ,   Presentation Master ,   Oceania ,   DMN Newswire ,   BN - Webcast ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   Streamline Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines